Potential improvements in convenience, tolerability of hematologic treatmentJuly 19, 2019Patient & Survivor CareMultiple MyelomaCLL
Hematology NewsSC daratumumab deemed feasible for every multiple myeloma patientJuly 11, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Oncology PracticeRecombinant vaccine cut herpes zoster rate in immunocompromised patientsJuly 9, 2019Patient & Survivor CareMultiple MyelomaTransplantTransplantation
Hematology NewsFDA approves Xpovio for relapsed/refractory multiple myelomaJuly 3, 2019Multiple Myeloma
Hematology NewsDaratumumab wins new indication for newly diagnosed myeloma patientsJune 28, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsTriplet offers longest PFS yet seen in relapsed/refractory myelomaJune 12, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology TimesFour-drug combo bests triplet in newly diagnosed myelomaJune 12, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsDaratumumab regimen shows benefit in transplant-ineligible myelomaMay 29, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsLenalidomide may reduce risk of progression from SMM to MMMay 16, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsCAR T-cell therapy bb2121 performs well in phase 1 trial of refractory multiple myelomaMay 1, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsQuality of life decrement with salvage ASCT is short-livedApril 23, 2019Multiple MyelomaTransplantTransplantationLymphoma & Plasma Cell DisordersPatient & Survivor Care
Hematology NewsASCO, CCO issue multiple myeloma treatment guidelinesApril 4, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsReal world responses mirror TOURMALINE-MM1 dataApril 4, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsCombo could replace standard conditioning regimen for myelomaApril 2, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsFDA halts enrollment in trial of venetoclax for multiple myelomaMarch 22, 2019Multiple Myeloma